2m 2m 2m 2m 2m 2m 2m
BRIACELL THERAP (BCTX)
NASDAQ
$3.36+$0.09 (+2.72%)
Price as of Jun 03, 2026 7:12 PM EDT- $26.4MMarket Cap
- -90.41%1-Year Change
- BiotechnologyIndustry
BRIACELL THERAP (BCTX)
$3.36+$0.09 (+2.72%)
BCTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.27 | ||
Change | -$0.04 (-1.21%) | ||
Open | $3.26 | ||
High | $3.41 | ||
Low | $3.20 | ||
Previous Close | $3.31 | ||
Volume | 211,827 | ||
30-Day Average Volume | 293,233 | ||
1-Week Change | -4.39% | ||
1-Month Change | -21.77% | ||
1-Year Change | -90.41% | ||
3-Year Change | -99.65% | ||
5-Year Change | -99.65% | ||
Fundamentals | |||
Shares Outstanding | 7.3M | ||
Total Assets | $33.6M | ||
Market Cap | $26.4M | ||
Enterprise Value | -$3.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$7.2M | ||
Free Cash Flow | -$8.0M | ||
EBIT | -$7.2M | ||
EBITDA | -$7.2M | ||
Net Working Capital | $29.0M | ||
EPS | -$2.58 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 08/25/2025 | ||
Earnings & Revenue